Impact of 22q11.2 deletion on the postoperative course of children after cardiac surgery

Pediatric Cardiology

Volumn 34, Issue 2, 2013, Pages 341-347

  McDonald, Rachel ^a   Dodgen, Andrew ^a   Goyal, Sunali ^a   Gossett, Jeffrey M ^a   Shinkawa, Takeshi ^a   Uppu, Santosh C ^a   Blanco, Carlos ^a   Garcia, Xiomara ^a   Bhutta, Adnan T ^a   Imamura, Michiaki ^a   Gupta, Punkaj ^a  

^a UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

22q11 deletion; Congenital heart disease; Intensive care unit; Interrupted aortic arch; Length of stay; Mechanical ventilation; Mortality; Tetralogy of Fallot; Truncus arteriosus

Indexed keywords

INOTROPIC AGENT;

ADOLESCENT; ADULT; AORTA ARCH INTERRUPTION; ARTERIAL TRUNK; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHROMOSOME DELETION 22Q11; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FALLOT TETRALOGY; HEART SURGERY; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEART DEFECTS, CONGENITAL; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84879501769     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0454-x     Document Type: Article

References (21)

1. Ackerman MJ, Wylam ME, Feldt RH, Porter CJ, Dewald G, Scanlon PD et al (2001) Pulmonary atresia with ventricular septal defect and persistent airway hyperresponsiveness. J Thorac Cardiovasc Surg 122:169-177
2. Carotti A, Marino B, Di Donato RM (2003) Influence of chromosome 22q11.2 microdeletion on surgical outcome after treatment of tetralogy of Fallot with pulmonary atresia. J Thorac Cardiovasc Surg 126:1666-1667
3. Carotti A, Digilio MC, Piacentini G, Saffirio C, Di Donato RM, Marino B (2008) Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome. Dev Disabil Res Rev 14:35-42
4. Carotti A, Albanese SB, Filippelli S, Ravà L, Guccione P, Pongiglione G, Di Donato RM (2010) Determinants of outcome after surgical treatment of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg 140:1092-1103
5. Cullen SM, Cronk CE, Pueschel SM, Schnell RR, Reed RB (1981) Social development and feeding milestones of young Down syndrome children. Am J Ment Defic 85:410-415
6. Duke SG, McGuirt WF, Jewett T et al (2000) Velocardiofacial syndrome: incidence of immune cytopenias. Arch Otolaryngol Head Neck Surg 126:1141-1145
7. Fudge JC Jr, Li S, Jaggers J, O'Brien SM, Peterson ED, Jacobs JP, Welke KF, Jacobs ML, Li JS, Pasquali SK (2010) Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. Pediatrics 126:315-322
8. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L et al (1998) Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 32:492-498
9. Jatana V, Gillis J, Webster BH, Adès LC (2007) Deletion 22q11.2 syndrome: implications for the intensive care physician. Pediatr Crit Care Med 8:459-463
10. Jedele KB, Michels VV, Puga FJ, Feldt RH (1992) Velocardiofacial syndrome associated with ventricular septal defect, pulmonary atresia, and hypoplastic pulmonary arteries. Pediatrics 89:915-919
11. Lipson AH, Yuille D, Angel M et al (1991) Velocardiofacial (Shprintzen) syndrome: an important syndrome for the dysmorphologist to recognise. J Med Genet 28:596-604
12. Maeda J, Yamagishi H, Matsuoka R, Ishihara J, Tokumura M, Fukushima H et al (2000) Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am J Med Genet 92:269-272
13. Mahle WT, Crisalli J, Coleman K, Campbell RM, Tam VK, Vincent RN, Kanter KR (2003) Deletion of chromosome 22q11.2 and outcome in patients with pulmonary atresia and ventricular septal defect. Ann Thorac Surg 76:567-571
14. Marino B, Digilio MC (2000) Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol 9:303-315
15. Michielon G, Marino B, Oricchio G, Digilio MC, Iorio F, Filippelli S, Placidi S, Di Donato RM (2009) Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects. J Thorac Cardiovasc Surg 138:565-570
16. Ryan AK, Goodship JA, Wilson DI et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798-804
17. Simsic JM, Coleman K, Maher KO, Cuadrado A, Kirshbom PM (2009) Do neonates with genetic abnormalities have an increased morbidity and mortality following cardiac surgery? Congenit Heart Dis 4:160-165
18. Sullivan KE, Jawad AF, Randall P et al (1998) Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic featured in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 86:141-146
19. Tezenas du Montcel S, Mendizabal H, Ayme S, Levy A, Philip N (1996) Prevalence of 22q11 microdeletion. J Med Genet 33:719
20. Van Mierop LHS, Kutsche LM (1986) Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor. Am J Cardiol 58:133-137
21. Wilson DI, Burn J, Scambler P, Goodship J (1993) DiGeorge syndrome: part of CATCH 22. J Med Genet 30:852-856